Open AccessREAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY
Author(s) -
Adrian Koh,
Timothy Y Y Lai,
Wen Bin Wei,
Ryusaburo Mori,
Harumi Wakiyama,
Kyu Hyung Park,
Fariza Ngah,
Wayne Macfadden,
Cornelia DungerBaldauf,
Soumil Parikh
Publication year - 2020
Publication title -
retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000002624
Subject(s) - ranibizumab , medicine , visual acuity , ophthalmology , macular degeneration , adverse effect , retinal , surgery , chemotherapy , bevacizumab
To evaluate the real-world effectiveness and safety of intravitreal ranibizumab 0.5 mg in treatment-naive patients with and without polypoidal choroidal vasculopathy (PCV).